Fintel reports that on December 23, 2024, D. Boral Capital initiated coverage of Omeros (NasdaqGM:OMER) with a Buy ...

Omeros reports that narsoplimab has not raised any notable safety issues across all clinical studies. For the treatment of TA ...

Omeros (OMER) announced that an independent statistical group has completed the primary statistical analysis agreed with the FDA for ...

TD Cowen initiated coverage of Dianthus (DNTH) with a Buy rating and no price target The firm says DNTH103 is “highly potent” and selectively ...

SAN DIEGO - December 20, 2024 (Investorideas.com Newswire) Aethlon Medical, Inc. ( Nasdaq: AEMD ), a medical therapeutic ...

Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and ...

Omeros announces positive results from a pivotal narsoplimab trial in TA-TMA, showing significant survival benefits and advancing regulatory submissions.

The stock has had big gains in this morning's trading session following an update on the company's Hemopurifier device in the treatment of Bird Flu. The stock is trading at $0.5761, up 0.1427, gaining ...

TMA-001, demonstrated clinically meaningful and statistically significant superiority in overall survival, prompting Omeros ...

TMA-001, compared overall survival in 28 TA-TMA patients treated with narsoplimab to more than 100 high-risk TA-TMA patients in an external control registry who did not receive the treatment. The ...

However, the seeds are also well known because they contain the highly poisonous protein abrin. This is a plant lectin, related to ricin, that inhibits cellular protein synthesis. Therefore Abrus ...

Radians®, a leading PPE manufacturer, partners with the Memphis St. Patrick Parish Pastoral Council in their mission to provide warm apparel for Memphians in need of warmth this holiday season and in ...